1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immunohistochemistry
1.2.3 Molecular Diagnosis
1.3 Market by Application
1.3.1 Global Companion Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Virology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Market Perspective (2017-2028)
2.2 Companion Diagnostic Growth Trends by Region
2.2.1 Companion Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Companion Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 Companion Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 Companion Diagnostic Market Dynamics
2.3.1 Companion Diagnostic Industry Trends
2.3.2 Companion Diagnostic Market Drivers
2.3.3 Companion Diagnostic Market Challenges
2.3.4 Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Players by Revenue
3.1.1 Global Top Companion Diagnostic Players by Revenue (2017-2022)
3.1.2 Global Companion Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Revenue
3.4 Global Companion Diagnostic Market Concentration Ratio
3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2021
3.5 Companion Diagnostic Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Breakdown Data by Type
4.1 Global Companion Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global Companion Diagnostic Forecasted Market Size by Type (2023-2028)
5 Companion Diagnostic Breakdown Data by Application
5.1 Global Companion Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Companion Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Companion Diagnostic Market Size (2017-2028)
6.2 North America Companion Diagnostic Market Size by Type
6.2.1 North America Companion Diagnostic Market Size by Type (2017-2022)
6.2.2 North America Companion Diagnostic Market Size by Type (2023-2028)
6.2.3 North America Companion Diagnostic Market Share by Type (2017-2028)
6.3 North America Companion Diagnostic Market Size by Application
6.3.1 North America Companion Diagnostic Market Size by Application (2017-2022)
6.3.2 North America Companion Diagnostic Market Size by Application (2023-2028)
6.3.3 North America Companion Diagnostic Market Share by Application (2017-2028)
6.4 North America Companion Diagnostic Market Size by Country
6.4.1 North America Companion Diagnostic Market Size by Country (2017-2022)
6.4.2 North America Companion Diagnostic Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Companion Diagnostic Market Size (2017-2028)
7.2 Europe Companion Diagnostic Market Size by Type
7.2.1 Europe Companion Diagnostic Market Size by Type (2017-2022)
7.2.2 Europe Companion Diagnostic Market Size by Type (2023-2028)
7.2.3 Europe Companion Diagnostic Market Share by Type (2017-2028)
7.3 Europe Companion Diagnostic Market Size by Application
7.3.1 Europe Companion Diagnostic Market Size by Application (2017-2022)
7.3.2 Europe Companion Diagnostic Market Size by Application (2023-2028)
7.3.3 Europe Companion Diagnostic Market Share by Application (2017-2028)
7.4 Europe Companion Diagnostic Market Size by Country
7.4.1 Europe Companion Diagnostic Market Size by Country (2017-2022)
7.4.2 Europe Companion Diagnostic Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific Companion Diagnostic Market Size by Type
8.2.1 Asia-Pacific Companion Diagnostic Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Companion Diagnostic Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Companion Diagnostic Market Share by Type (2017-2028)
8.3 Asia-Pacific Companion Diagnostic Market Size by Application
8.3.1 Asia-Pacific Companion Diagnostic Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Companion Diagnostic Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Companion Diagnostic Market Share by Application (2017-2028)
8.4 Asia-Pacific Companion Diagnostic Market Size by Region
8.4.1 Asia-Pacific Companion Diagnostic Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Companion Diagnostic Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Companion Diagnostic Market Size (2017-2028)
9.2 Latin America Companion Diagnostic Market Size by Type
9.2.1 Latin America Companion Diagnostic Market Size by Type (2017-2022)
9.2.2 Latin America Companion Diagnostic Market Size by Type (2023-2028)
9.2.3 Latin America Companion Diagnostic Market Share by Type (2017-2028)
9.3 Latin America Companion Diagnostic Market Size by Application
9.3.1 Latin America Companion Diagnostic Market Size by Application (2017-2022)
9.3.2 Latin America Companion Diagnostic Market Size by Application (2023-2028)
9.3.3 Latin America Companion Diagnostic Market Share by Application (2017-2028)
9.4 Latin America Companion Diagnostic Market Size by Country
9.4.1 Latin America Companion Diagnostic Market Size by Country (2017-2022)
9.4.2 Latin America Companion Diagnostic Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa Companion Diagnostic Market Size by Type
10.2.1 Middle East & Africa Companion Diagnostic Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Companion Diagnostic Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Companion Diagnostic Market Share by Type (2017-2028)
10.3 Middle East & Africa Companion Diagnostic Market Size by Application
10.3.1 Middle East & Africa Companion Diagnostic Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Companion Diagnostic Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Companion Diagnostic Market Share by Application (2017-2028)
10.4 Middle East & Africa Companion Diagnostic Market Size by Country
10.4.1 Middle East & Africa Companion Diagnostic Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Companion Diagnostic Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Holdings
11.1.1 Roche Holdings Company Details
11.1.2 Roche Holdings Business Overview
11.1.3 Roche Holdings Companion Diagnostic Introduction
11.1.4 Roche Holdings Revenue in Companion Diagnostic Business (2017-2022)
11.1.5 Roche Holdings Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Companion Diagnostic Introduction
11.2.4 Abbott Laboratories Revenue in Companion Diagnostic Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Companion Diagnostic Introduction
11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2017-2022)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Companion Diagnostic Introduction
11.4.4 Agilent Technologies Revenue in Companion Diagnostic Business (2017-2022)
11.4.5 Agilent Technologies Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Companion Diagnostic Introduction
11.5.4 Merck Revenue in Companion Diagnostic Business (2017-2022)
11.5.5 Merck Recent Developments
11.6 Agendia
11.6.1 Agendia Company Details
11.6.2 Agendia Business Overview
11.6.3 Agendia Companion Diagnostic Introduction
11.6.4 Agendia Revenue in Companion Diagnostic Business (2017-2022)
11.6.5 Agendia Recent Developments
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Companion Diagnostic Introduction
11.7.4 Qiagen Revenue in Companion Diagnostic Business (2017-2022)
11.7.5 Qiagen Recent Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Details
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Companion Diagnostic Introduction
11.8.4 Myriad Genetics Revenue in Companion Diagnostic Business (2017-2022)
11.8.5 Myriad Genetics Recent Developments
11.9 Advanced Cell Diagnostics
11.9.1 Advanced Cell Diagnostics Company Details
11.9.2 Advanced Cell Diagnostics Business Overview
11.9.3 Advanced Cell Diagnostics Companion Diagnostic Introduction
11.9.4 Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2017-2022)
11.9.5 Advanced Cell Diagnostics Recent Developments
11.10 Danaher
11.10.1 Danaher Company Details
11.10.2 Danaher Business Overview
11.10.3 Danaher Companion Diagnostic Introduction
11.10.4 Danaher Revenue in Companion Diagnostic Business (2017-2022)
11.10.5 Danaher Recent Developments
11.11 Illumina, Inc
11.11.1 Illumina, Inc Company Details
11.11.2 Illumina, Inc Business Overview
11.11.3 Illumina, Inc Companion Diagnostic Introduction
11.11.4 Illumina, Inc Revenue in Companion Diagnostic Business (2017-2022)
11.11.5 Illumina, Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Companion Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Immunohistochemistry
Table 3. Key Players of Molecular Diagnosis
Table 4. Global Companion Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Companion Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Companion Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Companion Diagnostic Market Share by Region (2017-2022)
Table 8. Global Companion Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Companion Diagnostic Market Share by Region (2023-2028)
Table 10. Companion Diagnostic Market Trends
Table 11. Companion Diagnostic Market Drivers
Table 12. Companion Diagnostic Market Challenges
Table 13. Companion Diagnostic Market Restraints
Table 14. Global Companion Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Companion Diagnostic Revenue Share by Players (2017-2022)
Table 16. Global Top Companion Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021)
Table 17. Ranking of Global Top Companion Diagnostic Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Companion Diagnostic Product Solution and Service
Table 21. Date of Enter into Companion Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Companion Diagnostic Revenue Market Share by Type (2017-2022)
Table 25. Global Companion Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Companion Diagnostic Revenue Market Share by Type (2023-2028)
Table 27. Global Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Companion Diagnostic Revenue Share by Application (2017-2022)
Table 29. Global Companion Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Companion Diagnostic Revenue Share by Application (2023-2028)
Table 31. North America Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Companion Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Companion Diagnostic Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 61. Roche Holdings Company Details
Table 62. Roche Holdings Business Overview
Table 63. Roche Holdings Companion Diagnostic Product
Table 64. Roche Holdings Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 65. Roche Holdings Recent Developments
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Companion Diagnostic Product
Table 69. Abbott Laboratories Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 70. Abbott Laboratories Recent Developments
Table 71. Thermo Fisher Scientific Company Details
Table 72. Thermo Fisher Scientific Business Overview
Table 73. Thermo Fisher Scientific Companion Diagnostic Product
Table 74. Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 75. Thermo Fisher Scientific Recent Developments
Table 76. Agilent Technologies Company Details
Table 77. Agilent Technologies Business Overview
Table 78. Agilent Technologies Companion Diagnostic Product
Table 79. Agilent Technologies Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 80. Agilent Technologies Recent Developments
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Companion Diagnostic Product
Table 84. Merck Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 85. Merck Recent Developments
Table 86. Agendia Company Details
Table 87. Agendia Business Overview
Table 88. Agendia Companion Diagnostic Product
Table 89. Agendia Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 90. Agendia Recent Developments
Table 91. Qiagen Company Details
Table 92. Qiagen Business Overview
Table 93. Qiagen Companion Diagnostic Product
Table 94. Qiagen Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 95. Qiagen Recent Developments
Table 96. Myriad Genetics Company Details
Table 97. Myriad Genetics Business Overview
Table 98. Myriad Genetics Companion Diagnostic Product
Table 99. Myriad Genetics Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 100. Myriad Genetics Recent Developments
Table 101. Advanced Cell Diagnostics Company Details
Table 102. Advanced Cell Diagnostics Business Overview
Table 103. Advanced Cell Diagnostics Companion Diagnostic Product
Table 104. Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 105. Advanced Cell Diagnostics Recent Developments
Table 106. Danaher Company Details
Table 107. Danaher Business Overview
Table 108. Danaher Companion Diagnostic Product
Table 109. Danaher Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 110. Danaher Recent Developments
Table 111. Illumina, Inc Company Details
Table 112. Illumina, Inc Business Overview
Table 113. Illumina, Inc Companion Diagnostic Product
Table 114. Illumina, Inc Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
Table 115. Illumina, Inc Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Market Share by Type: 2021 VS 2028
Figure 2. Immunohistochemistry Features
Figure 3. Molecular Diagnosis Features
Figure 4. Global Companion Diagnostic Market Share by Application: 2021 VS 2028
Figure 5. Oncology Case Studies
Figure 6. Cardiovascular Case Studies
Figure 7. Central Nervous System Case Studies
Figure 8. Virology Case Studies
Figure 9. Others Case Studies
Figure 10. Companion Diagnostic Report Years Considered
Figure 11. Global Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Companion Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Companion Diagnostic Market Share by Region: 2021 VS 2028
Figure 14. Global Companion Diagnostic Market Share by Players in 2021
Figure 15. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Companion Diagnostic Revenue in 2021
Figure 17. North America Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Companion Diagnostic Market Size Market Share by Type (2017-2028)
Figure 19. North America Companion Diagnostic Market Size Market Share by Application (2017-2028)
Figure 20. North America Companion Diagnostic Market Size Share by Country (2017-2028)
Figure 21. United States Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Companion Diagnostic Market Size Market Share by Type (2017-2028)
Figure 25. Europe Companion Diagnostic Market Size Market Share by Application (2017-2028)
Figure 26. Europe Companion Diagnostic Market Size Share by Country (2017-2028)
Figure 27. Germany Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Companion Diagnostic Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Companion Diagnostic Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Companion Diagnostic Market Size Share by Region (2017-2028)
Figure 37. China Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Companion Diagnostic Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Companion Diagnostic Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Companion Diagnostic Market Size Share by Country (2017-2028)
Figure 47. Mexico Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Companion Diagnostic Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Companion Diagnostic Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Companion Diagnostic Market Size Share by Country (2017-2028)
Figure 53. Turkey Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Roche Holdings Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 57. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 59. Agilent Technologies Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 60. Merck Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 61. Agendia Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 62. Qiagen Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 63. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 64. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 65. Danaher Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 66. Illumina, Inc Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
